Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
NPJ Genomic Medicine|January 15, 2026
Distinguishing benign from pathogenic duplications involving GPR101 and VGLL1-adjacent enhancers in the clinical setting with the bioinformatic tool POSTREGiampaolo Trivellin, Víctor Sánchez-Gaya, Alexia Grasso, et al.
Clinical Neurology and Neurosurgery|February 21, 2006
Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patientsAnnie S Dubuisson, Albert Beckers, Achille Stevenaert
Neuroendocrinology|September 11, 2010
Medical treatment in Cushing's syndrome: dopamine agonists and cabergolinePatrick Petrossians, Anne-Sophie Thonnard, Albert Beckers
Pituitary|February 16, 2017
T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspectiveIulia Potorac, Albert Beckers, Jean-François Bonneville
Frontiers in Endocrinology|September 15, 2023
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the aryl hydrocarbon receptor interacting protein (AIP) geneLaurent Vroonen, Albert Beckers, Severine Camby, et al.
Endocrine-Related Cancer|March 11, 2016
Screening for GPR101 defects in pediatric pituitary corticotropinomasGiampaolo Trivellin, Ricardo R Correa, Maria Batsis, et al.
Annales D'Endocrinologie|February 15, 2016
High prevalence of autoimmune thyroid diseases in patients with prolactinomas: A cross-sectional retrospective study in a single tertiary referral centreAtanaska Elenkova, Patrick Petrossians, Sabina Zacharieva, et al.
F1000 Medicine Reports|December 22, 2010
Management of acromegalyVladimir Vasilev, Adrian Daly, Sabina Zacharieva, et al.
European Journal of Endocrinology|June 6, 2019
Excellent response to pasireotide therapy in an aggressive and dopamine-resistant prolactinomaEva C Coopmans, Sebastiaan W F van Meyel, Kay J Pieterman, et al.
Endocrine-Related Cancer|April 1, 2011
Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutationChiara Villa, Maria Stefania Lagonigro, Flavia Magri, et al.
Pageof 17